Innovative drug development methods and tools are developed and used by pharmaceutical industry, clinical research organisations, public/private partnerships, and academic researchers to decrease cost and time to market and to increase the probability of success of pharmaceuticals R&D. Novel clinical trial methodologies based on stringent scientific criteria have gained acceptance for successful regulatory approval. The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have established formal advice procedures for qualification of such methodologies, in consultation with the scientific community.
This workshop was presented by Fundisa African Academy of Medicines Development and Pharmacometrics Africa to provide insights into the use of modelling and simulation, adaptive trial designs and real-world effectiveness studies by local and international experts with hands-on experience. Over 50 delegates from academia, industry, regulatory agencies and ethics committees attended this interactive forum of presentations and discussions.
Agenda and Links to Presentations:
Meeting Host and Opening Remarks: Bernd Rosenkranz
Modeling and Simulation (Chair: Phumla Sinxadi)
Modelling the dynamics and control of infectious diseases: the example of tuberculosis (Florian Marx)
Pharmacokinetic and pharmacodynamic modelling (Leon Aarons)
Novel clinical trial designs for optimizing parameter estimation in malaria disease-drug models (Joel S. Owen)
South African clinical trials database - an update (Duduzile Nwandwe & Lindi Mathebula)
Global health working group for the Trials Methodology Research Partnership (Elizabeth Allen)
Clinical Trial Designs (Chair: Colin Pillai)
Presentation Materials
The detailed agenda and all presentation materials are available for download from the Fundisa Academy website or by following the hyperlinks above.
For enquiries, please contact info@fundisa-academy.com